Cargando…

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy

PURPOSE: To construct an immune-related gene prognostic index (IRGPI) for colon cancer and elucidate the molecular and immune characteristics as well as the benefit of immune checkpoint inhibitor (ICI) therapy in IRGPI-defined groups of colon cancer. EXPERIMENTAL DESIGN: Transcriptional and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zheng, Song, Jingru, Azami, Nisma Lena Bahaji, Sun, Mingyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095944/ https://www.ncbi.nlm.nih.gov/pubmed/35572595 http://dx.doi.org/10.3389/fimmu.2022.802665

Ejemplares similares

Zeaxanthin Dipalmitate in the Treatment of Liver Disease
por: Bahaji Azami, Nisma Lena, et al.
Publicado: (2019)

Research Progress of Intestinal Microecology in the Pathogenesis of Colorectal Adenoma and Carcinogenesis
por: Zhang, Zhipeng, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing
por: Yang, Jia, et al.
Publicado: (2023)

The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial
por: Hui, Dengcheng, et al.
Publicado: (2023)

Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
por: Li, Xinyu, et al.
Publicado: (2020)

Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome
por: Wu, Chao, et al.
Publicado: (2022)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
por: Chi, Hao, et al.
Publicado: (2022)

Immune landscape-based machine-learning–assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma
por: Li, Haiyan, et al.
Publicado: (2022)

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

Immune landscape and immunotherapy for penile cancer
por: Tang, Yaxiong, et al.
Publicado: (2022)

Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy
por: Zhou, Huandi, et al.
Publicado: (2023)

Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2022)

Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with Wilms tumour
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer
por: Yi, Xianyanling, et al.
Publicado: (2022)

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2023)

Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer
por: Yu, Sihui, et al.
Publicado: (2021)

Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer
por: Liu, Yilong, et al.
Publicado: (2022)

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
por: Zhou, Mingxuan, et al.
Publicado: (2022)

Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma
por: Ma, Xiaochen, et al.
Publicado: (2022)

Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
por: Zhao, Rongrong, et al.
Publicado: (2022)

Glioblastoma Immune Landscape and the Potential of New Immunotherapies
por: Daubon, Thomas, et al.
Publicado: (2020)

Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
por: Giraud, Julie, et al.
Publicado: (2021)

Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer
por: Luan, Likun, et al.
Publicado: (2022)

Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients
por: Zhang, Zi-jian, et al.
Publicado: (2023)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas
por: Li, Junhong, et al.
Publicado: (2023)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer
por: Zhang, Heng-Chun, et al.
Publicado: (2022)

A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma
por: Cheng, Xuehua, et al.
Publicado: (2022)

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
por: Ren, Qianhe, et al.
Publicado: (2023)

Comprehensive Analysis of a Cancer-Immunity Cycle–Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer
por: Hou, Yufang, et al.
Publicado: (2022)

Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma
por: Zhou, Guanwen, et al.
Publicado: (2023)

Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma
por: Xu, Fangxing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upfep3h9pil9r0pookec8ei8un